<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01229449</url>
  </required_header>
  <id_info>
    <org_study_id>NL0811</org_study_id>
    <nct_id>NCT01229449</nct_id>
  </id_info>
  <brief_title>Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain Study</brief_title>
  <official_title>A Double-blind, 5 Parallel-group, Placebo-controlled, Randomised, Single Dose, 3-site Study to Compare the Analgesic Efficacy and Tolerability of a Combination of Ibuprofen 400 mg Plus Paracetamol 1000 mg; a Combination of Ibuprofen 200 mg Plus Paracetamol 500 mg; a Combination of Ibuprofen 400 mg Plus Codeine 25.6 mg (Nurofen Plus®); a Combination of Paracetamol 1000 mg Plus Codeine 30 mg (Panadeine® Extra) in Postoperative Adult Dental Pain Following Third Molar Extraction.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reckitt Benckiser LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Premier Research Group plc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aptuit Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Reckitt Benckiser LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to assess the efficacy and tolerability of a combination of 400 mg ibuprofen
      plus 1000 mg acetaminophen, 200 mg ibuprofen plus 500 mg acetaminophen compared with Nurofen
      Plus® and Panadeine® Extra.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RB has developed a fixed-dose combination of ibuprofen and acetaminophen (paracetamol). Since
      the pharmacological actions of ibuprofen and acetaminophen (paracetamol) differ in their site
      and mode of action, the combination would be expected to be more effective than either active
      alone, given that pain is multi-factorial with different mediators.

      The purpose of this study was to compare the efficacy and tolerability of
      ibuprofen/acetaminophen (paracetamol) combination with leading market analgesics.

      The efficacy and tolerability was assessed in terms of total analgesic effect, peak analgesic
      effect, onset and duration of action and the subject's overall assessment of the study
      medication.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Area Under the Curve (AUC) of Pain Intensity and Relief Scores (SPRID)</measure>
    <time_frame>0 (baseline), 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 hours post-dose</time_frame>
    <description>SPRID 0-12h: Sum of pain intensity difference (PID) and the pain relief (PR) score over the twelve-hour follow-up period. Score range: 0mm = No pain and 100mm = Worst pain. This was calculated as the area under the curve (AUC) using the method of linear trapezoids assuming that the baseline assessment took place at time zero.
Pain intensity (PI) was measured by pain assessment questionnaire, where subject tick the appropriate box in a 4-point ordinal scale ranging from 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain, in response to the question 'What is your pain level at this time?'
Total Pain Relief (TOTPAR) was measured using pain assessment diary, where subject tick the appropriate box on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete, in response to the question 'How much relief have you had from your starting pain?'</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in AUC (0-8h) of SPRID</measure>
    <time_frame>0 (baseline), 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, and 8 hours post-dose</time_frame>
    <description>SPRID 0-8h: Sum of pain intensity difference (PID) and the pain relief (PR) score over the twelve-hour follow-up period. Score range: 0 mm = No pain and 100 mm = Worst pain. This was calculated as the area under the curve (AUC) using the method of linear trapezoids assuming that the baseline assessment took place at time zero.
Pain intensity (PI) was measured by pain assessment questionnaire, where subject tick the appropriate box in a 4-point ordinal scale ranging from 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain, in response to the question 'What is your pain level at this time?'
Total Pain Relief (TOTPAR) was measured using pain assessment diary, where subject tick the appropriate box on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete, in response to the question 'How much relief have you had from your starting pain?'</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in AUC for Pain Intensity Difference Scores (SPID)</measure>
    <time_frame>0-4, 0-6, 0-8 and 0-12 hours</time_frame>
    <description>Sum of Pain Intensity Difference (SPID) was calculated as the area under the curve (AUC) using the method of linear trapezoids assuming that the baseline assessment took place at time zero. Score range: 0mm = No pain and 100mm = Worst pain. Pain intensity (PI) was measured by pain assessment questionnaire, where subject tick the appropriate box in a 4-point ordinal scale ranging from 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain, in response to the question 'What is your pain level at this time?'</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in AUC of Pain Relief Scores (TOTPAR)</measure>
    <time_frame>0-4, 0-6, 0-8 and 0-12 hours</time_frame>
    <description>Total pain relief (TOTPAR) was measured using pain assessment diary where subject tick the appropriate box in response to the question 'How much relief have you had from your starting pain?'
Pain Relief (PR) was rated on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in AUC of Individual Reading Pain Intensity and Relief Scores (SPRID)</measure>
    <time_frame>15, 30, 45, 60, 90 minutes and 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 hours</time_frame>
    <description>SPRID 0-12h: Sum of pain intensity difference (PID) and the pain relief (PR) score over the twelve-hour follow-up period. Score range: 0mm = No pain and 100mm = Worst pain. This was calculated as the area under the curve (AUC) using the method of linear trapezoids assuming that the baseline assessment took place at time zero.
Pain intensity (PI) was measured by pain assessment questionnaire, where subject tick the appropriate box in a 4-point ordinal scale ranging from 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain, in response to the question 'What is your pain level at this time?'
Total Pain Relief (TOTPAR) was measured using pain assessment diary, where subject tick the appropriate box on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete, in response to the question 'How much relief have you had from your starting pain?'</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Individual Pain Intensity Differences (Ordinal)</measure>
    <time_frame>15, 30, 45, 60, 90 minutes and 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 hours</time_frame>
    <description>Pain intensity (PI) was measured by pain assessment questionnaire where subject tick the appropriate box in response to the question 'What is your pain level at this time?'
PI measured using a 4-point ordinal scale: 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Individual Pain Intensity Differences Visual Analogue Scale (VAS)</measure>
    <time_frame>15, 30, 45, 60, 90 minutes and 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 hours</time_frame>
    <description>Pain Intensity (PI) VAS was measured using a horizontal 100-mm VAS ranging 0 mm = 'No Pain' as the left anchor and 100 mm = 'Worst Pain' as the right anchor, labelled by the subject marking the VAS line in the pain assessment questionnaire in response to the instruction 'Please indicate with a line on the scale below your pain at this time.'</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Peak Pain Intensity Difference (Peak PID - Ordinal)</measure>
    <time_frame>0 (baseline), 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 hours post-dose</time_frame>
    <description>Pain intensity (PI) was measured by pain assessment questionnaire where subject tick the appropriate box in response to the question 'What is your pain level at this time?'
PI measured using a 4-point ordinal scale: 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Peak Pain Relief (PR)</measure>
    <time_frame>0 (baseline), 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 hours post-dose</time_frame>
    <description>Total pain relief (TOTPAR) was measured using pain assessment diary where subject tick the appropriate box in response to the question 'How much relief have you had from your starting pain?'
Pain Relief (PR) was rated on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjects' Overall Assessment of the Study Medication Assessed at 12 Hours or Just Before Administration of Rescue Medication</measure>
    <time_frame>At 12 hours</time_frame>
    <description>Subject's Overall Assessment measured by subject ticking the appropriate box in response to the question 'How effective do you think the study medication is as a treatment for pain?'
Subject's Overall Assessment rated on a five-point ordinal scale: 1 = Poor, 2 = Fair, 3 = Good, 4 = Very good, and 5 = Excellent.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">678</enrollment>
  <condition>Post-operative Pain</condition>
  <arm_group>
    <arm_group_label>Ibuprofen/acetaminophen (lower dose)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen/acetaminophen (higher dose)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nurofen Plus®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Panadeine® Extra</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Two placebo tablets</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen/acetaminophen</intervention_name>
    <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet, single dose taken orally with 300 ml water</description>
    <arm_group_label>Ibuprofen/acetaminophen (lower dose)</arm_group_label>
    <other_name>Ibuprofen/paracetamol (lower dose)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen/acetaminophen (higher dose)</intervention_name>
    <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg, single dose taken orally with 300 ml water</description>
    <arm_group_label>Ibuprofen/acetaminophen (higher dose)</arm_group_label>
    <other_name>Ibuprofen/Paracetamol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nurofen Plus®</intervention_name>
    <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®), single dose taken orally with 300 ml water</description>
    <arm_group_label>Nurofen Plus®</arm_group_label>
    <other_name>Ibuprofen/Codeine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Panadeine® Extra</intervention_name>
    <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra), single dose taken orally with 300 ml water</description>
    <arm_group_label>Panadeine® Extra</arm_group_label>
    <other_name>Acetaminophen/codeine</other_name>
    <other_name>Paracetamol/codeine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Two placebo tablets, single dose taken orally with 300 ml water</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Main Inclusion Criteria:

        Experiencing moderate to severe pain after extraction of impacted third molars

        Main Exclusion Criteria:

        Any ongoing painful condition other than that associated with the current third molar
        surgery that could significantly interfere with the subject's suitability Any condition
        that would render the subject unsuitable to receive an NSAID, acetaminophen or codeine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen Daniels</last_name>
    <role>Principal Investigator</role>
    <affiliation>Premier Research Group Inc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Premier Research</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>October 26, 2010</study_first_submitted>
  <study_first_submitted_qc>October 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2010</study_first_posted>
  <results_first_submitted>July 11, 2011</results_first_submitted>
  <results_first_submitted_qc>August 14, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">September 17, 2018</results_first_posted>
  <last_update_submitted>August 14, 2018</last_update_submitted>
  <last_update_submitted_qc>August 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dental pain</keyword>
  <keyword>Ibuprofen</keyword>
  <keyword>Acetaminophen</keyword>
  <keyword>Nurofen Plus®</keyword>
  <keyword>Panadeine® Extra</keyword>
  <keyword>Paracetamol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Toothache</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Codeine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were recruited in three centres, Salt Lake City (243 subjects randomised), San Marcos (229 subjects randomised) and Austin (206 subjects randomised)</recruitment_details>
      <pre_assignment_details>A total of 678 subjects were randomised into the study.173 subjects received ibuprofen 200 mg + paracetamol 500 mg, 169 subjects received Nurofen Plus®, 168 subjects received ibuprofen 400 mg + paracetamol 1000 mg, 113 subjects received Panadeine® Extra and 55 subjects received placebo.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Ibuprofen 200mg + Paracetamol 500mg (Lower Dose)</title>
          <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet by mouth (single dose)</description>
        </group>
        <group group_id="P2">
          <title>Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose)</title>
          <description>Two tablets of ibuprofen 200 mg plus two tablets of acetaminophen 500 mg by mouth (single dose)</description>
        </group>
        <group group_id="P3">
          <title>Nurofen Plus®</title>
          <description>Two tablets ibuprofen 200 mg plus codeine 12.8 mg (Nurofen Plus®) by mouth (single dose)</description>
        </group>
        <group group_id="P4">
          <title>Panadeine® Extra</title>
          <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra) by mouth (single dose)</description>
        </group>
        <group group_id="P5">
          <title>Placebo</title>
          <description>Two placebo tablets by mouth</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="173"/>
                <participants group_id="P2" count="168"/>
                <participants group_id="P3" count="169"/>
                <participants group_id="P4" count="113"/>
                <participants group_id="P5" count="55"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="172"/>
                <participants group_id="P2" count="164"/>
                <participants group_id="P3" count="167"/>
                <participants group_id="P4" count="112"/>
                <participants group_id="P5" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ibuprofen 200mg + Paracetamol 500mg (Lower Dose)</title>
          <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet by mouth</description>
        </group>
        <group group_id="B2">
          <title>Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose)</title>
          <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg by mouth</description>
        </group>
        <group group_id="B3">
          <title>Nurofen Plus®</title>
          <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®) by mouth</description>
        </group>
        <group group_id="B4">
          <title>Panadeine® Extra</title>
          <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra) by mouth</description>
        </group>
        <group group_id="B5">
          <title>Placebo</title>
          <description>Two placebo tablets by mouth</description>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="173"/>
            <count group_id="B2" value="168"/>
            <count group_id="B3" value="169"/>
            <count group_id="B4" value="113"/>
            <count group_id="B5" value="55"/>
            <count group_id="B6" value="678"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20.2" spread="3.3"/>
                    <measurement group_id="B2" value="19.8" spread="3.2"/>
                    <measurement group_id="B3" value="20.1" spread="3.4"/>
                    <measurement group_id="B4" value="19.7" spread="3.3"/>
                    <measurement group_id="B5" value="19.8" spread="3.6"/>
                    <measurement group_id="B6" value="20.0" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="105"/>
                    <measurement group_id="B2" value="100"/>
                    <measurement group_id="B3" value="101"/>
                    <measurement group_id="B4" value="68"/>
                    <measurement group_id="B5" value="33"/>
                    <measurement group_id="B6" value="407"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                    <measurement group_id="B2" value="68"/>
                    <measurement group_id="B3" value="68"/>
                    <measurement group_id="B4" value="45"/>
                    <measurement group_id="B5" value="22"/>
                    <measurement group_id="B6" value="271"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="165"/>
                    <measurement group_id="B2" value="158"/>
                    <measurement group_id="B3" value="154"/>
                    <measurement group_id="B4" value="107"/>
                    <measurement group_id="B5" value="51"/>
                    <measurement group_id="B6" value="635"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="173"/>
                    <measurement group_id="B2" value="168"/>
                    <measurement group_id="B3" value="169"/>
                    <measurement group_id="B4" value="113"/>
                    <measurement group_id="B5" value="55"/>
                    <measurement group_id="B6" value="678"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68.1" spread="14.5"/>
                    <measurement group_id="B2" value="69.0" spread="15.2"/>
                    <measurement group_id="B3" value="68.8" spread="15.3"/>
                    <measurement group_id="B4" value="70.8" spread="16.1"/>
                    <measurement group_id="B5" value="71.0" spread="18.7"/>
                    <measurement group_id="B6" value="69.2" spread="15.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="168.5" spread="10.0"/>
                    <measurement group_id="B2" value="169.3" spread="10.1"/>
                    <measurement group_id="B3" value="169.5" spread="9.8"/>
                    <measurement group_id="B4" value="168.5" spread="9.7"/>
                    <measurement group_id="B5" value="168.7" spread="9.5"/>
                    <measurement group_id="B6" value="168.9" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Drink alcohol</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="61"/>
                    <measurement group_id="B4" value="36"/>
                    <measurement group_id="B5" value="15"/>
                    <measurement group_id="B6" value="236"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Former smoker</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="13"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Current smoker</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Used drugs of abuse</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="37"/>
                    <measurement group_id="B4" value="18"/>
                    <measurement group_id="B5" value="8"/>
                    <measurement group_id="B6" value="126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Area Under the Curve (AUC) of Pain Intensity and Relief Scores (SPRID)</title>
        <description>SPRID 0-12h: Sum of pain intensity difference (PID) and the pain relief (PR) score over the twelve-hour follow-up period. Score range: 0mm = No pain and 100mm = Worst pain. This was calculated as the area under the curve (AUC) using the method of linear trapezoids assuming that the baseline assessment took place at time zero.
Pain intensity (PI) was measured by pain assessment questionnaire, where subject tick the appropriate box in a 4-point ordinal scale ranging from 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain, in response to the question 'What is your pain level at this time?'
Total Pain Relief (TOTPAR) was measured using pain assessment diary, where subject tick the appropriate box on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete, in response to the question 'How much relief have you had from your starting pain?'</description>
        <time_frame>0 (baseline), 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 hours post-dose</time_frame>
        <population>Intention-to-treat (ITT) population includes all randomized subjects who took the study medication, completed the baseline efficacy assessments and had at least one post-baseline assessment. Any subjects with treatment administration errors were analyzed according to the treatment to which they were randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen 200mg + Paracetamol 500mg (Lower Dose)</title>
            <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet by mouth</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose)</title>
            <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg by mouth</description>
          </group>
          <group group_id="O3">
            <title>Nurofen Plus®</title>
            <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®) by mouth</description>
          </group>
          <group group_id="O4">
            <title>Panadeine® Extra</title>
            <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra) by mouth</description>
          </group>
          <group group_id="O5">
            <title>Placebo</title>
            <description>Two placebo tablets by mouth</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Area Under the Curve (AUC) of Pain Intensity and Relief Scores (SPRID)</title>
          <description>SPRID 0-12h: Sum of pain intensity difference (PID) and the pain relief (PR) score over the twelve-hour follow-up period. Score range: 0mm = No pain and 100mm = Worst pain. This was calculated as the area under the curve (AUC) using the method of linear trapezoids assuming that the baseline assessment took place at time zero.
Pain intensity (PI) was measured by pain assessment questionnaire, where subject tick the appropriate box in a 4-point ordinal scale ranging from 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain, in response to the question 'What is your pain level at this time?'
Total Pain Relief (TOTPAR) was measured using pain assessment diary, where subject tick the appropriate box on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete, in response to the question 'How much relief have you had from your starting pain?'</description>
          <population>Intention-to-treat (ITT) population includes all randomized subjects who took the study medication, completed the baseline efficacy assessments and had at least one post-baseline assessment. Any subjects with treatment administration errors were analyzed according to the treatment to which they were randomized.</population>
          <units>units on a scale*hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="173"/>
                <count group_id="O2" value="168"/>
                <count group_id="O3" value="169"/>
                <count group_id="O4" value="113"/>
                <count group_id="O5" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.68" spread="1.59"/>
                    <measurement group_id="O2" value="3.30" spread="1.67"/>
                    <measurement group_id="O3" value="2.62" spread="1.73"/>
                    <measurement group_id="O4" value="1.93" spread="1.51"/>
                    <measurement group_id="O5" value="0.54" spread="1.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0001</p_value>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0001</p_value>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.72</p_value>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0005</p_value>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0005</p_value>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in AUC (0-8h) of SPRID</title>
        <description>SPRID 0-8h: Sum of pain intensity difference (PID) and the pain relief (PR) score over the twelve-hour follow-up period. Score range: 0 mm = No pain and 100 mm = Worst pain. This was calculated as the area under the curve (AUC) using the method of linear trapezoids assuming that the baseline assessment took place at time zero.
Pain intensity (PI) was measured by pain assessment questionnaire, where subject tick the appropriate box in a 4-point ordinal scale ranging from 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain, in response to the question 'What is your pain level at this time?'
Total Pain Relief (TOTPAR) was measured using pain assessment diary, where subject tick the appropriate box on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete, in response to the question 'How much relief have you had from your starting pain?'</description>
        <time_frame>0 (baseline), 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, and 8 hours post-dose</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen 200mg + Paracetamol 500mg (Lower Dose)</title>
            <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet by mouth</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose)</title>
            <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg by mouth</description>
          </group>
          <group group_id="O3">
            <title>Nurofen Plus®</title>
            <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®) by mouth</description>
          </group>
          <group group_id="O4">
            <title>Panadeine® Extra</title>
            <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra) by mouth</description>
          </group>
          <group group_id="O5">
            <title>Placebo</title>
            <description>Two placebo tablets by mouth</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in AUC (0-8h) of SPRID</title>
          <description>SPRID 0-8h: Sum of pain intensity difference (PID) and the pain relief (PR) score over the twelve-hour follow-up period. Score range: 0 mm = No pain and 100 mm = Worst pain. This was calculated as the area under the curve (AUC) using the method of linear trapezoids assuming that the baseline assessment took place at time zero.
Pain intensity (PI) was measured by pain assessment questionnaire, where subject tick the appropriate box in a 4-point ordinal scale ranging from 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain, in response to the question 'What is your pain level at this time?'
Total Pain Relief (TOTPAR) was measured using pain assessment diary, where subject tick the appropriate box on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete, in response to the question 'How much relief have you had from your starting pain?'</description>
          <population>ITT population</population>
          <units>units on a scale*hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="173"/>
                <count group_id="O2" value="168"/>
                <count group_id="O3" value="169"/>
                <count group_id="O4" value="113"/>
                <count group_id="O5" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0-4h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.65" spread="1.60"/>
                    <measurement group_id="O2" value="3.95" spread="1.52"/>
                    <measurement group_id="O3" value="3.44" spread="1.72"/>
                    <measurement group_id="O4" value="3.19" spread="1.61"/>
                    <measurement group_id="O5" value="0.61" spread="1.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0-6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.66" spread="1.68"/>
                    <measurement group_id="O2" value="4.06" spread="1.64"/>
                    <measurement group_id="O3" value="3.45" spread="1.82"/>
                    <measurement group_id="O4" value="2.86" spread="1.62"/>
                    <measurement group_id="O5" value="0.60" spread="1.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0-8h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.39" spread="1.71"/>
                    <measurement group_id="O2" value="3.91" spread="1.69"/>
                    <measurement group_id="O3" value="3.22" spread="1.85"/>
                    <measurement group_id="O4" value="2.48" spread="1.57"/>
                    <measurement group_id="O5" value="0.57" spread="1.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in AUC for Pain Intensity Difference Scores (SPID)</title>
        <description>Sum of Pain Intensity Difference (SPID) was calculated as the area under the curve (AUC) using the method of linear trapezoids assuming that the baseline assessment took place at time zero. Score range: 0mm = No pain and 100mm = Worst pain. Pain intensity (PI) was measured by pain assessment questionnaire, where subject tick the appropriate box in a 4-point ordinal scale ranging from 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain, in response to the question 'What is your pain level at this time?'</description>
        <time_frame>0-4, 0-6, 0-8 and 0-12 hours</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen 200mg + Paracetamol 500mg (Lower Dose)</title>
            <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet by mouth</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose)</title>
            <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg by mouth</description>
          </group>
          <group group_id="O3">
            <title>Nurofen Plus®</title>
            <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®) by mouth</description>
          </group>
          <group group_id="O4">
            <title>Panadeine® Extra</title>
            <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra) by mouth</description>
          </group>
          <group group_id="O5">
            <title>Placebo</title>
            <description>Two placebo tablets by mouth</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in AUC for Pain Intensity Difference Scores (SPID)</title>
          <description>Sum of Pain Intensity Difference (SPID) was calculated as the area under the curve (AUC) using the method of linear trapezoids assuming that the baseline assessment took place at time zero. Score range: 0mm = No pain and 100mm = Worst pain. Pain intensity (PI) was measured by pain assessment questionnaire, where subject tick the appropriate box in a 4-point ordinal scale ranging from 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain, in response to the question 'What is your pain level at this time?'</description>
          <population>ITT population</population>
          <units>units on a scale*hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="173"/>
                <count group_id="O2" value="168"/>
                <count group_id="O3" value="169"/>
                <count group_id="O4" value="113"/>
                <count group_id="O5" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0-4h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.32" spread="0.73"/>
                    <measurement group_id="O2" value="1.46" spread="0.72"/>
                    <measurement group_id="O3" value="1.23" spread="0.75"/>
                    <measurement group_id="O4" value="1.13" spread="0.70"/>
                    <measurement group_id="O5" value="0.18" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0-6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.32" spread="0.74"/>
                    <measurement group_id="O2" value="1.50" spread="0.75"/>
                    <measurement group_id="O3" value="1.23" spread="0.76"/>
                    <measurement group_id="O4" value="1.01" spread="0.67"/>
                    <measurement group_id="O5" value="0.19" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0-8h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.21" spread="0.73"/>
                    <measurement group_id="O2" value="1.43" spread="0.75"/>
                    <measurement group_id="O3" value="1.14" spread="0.75"/>
                    <measurement group_id="O4" value="0.87" spread="0.63"/>
                    <measurement group_id="O5" value="0.19" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0-12h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.94" spread="0.64"/>
                    <measurement group_id="O2" value="1.18" spread="0.69"/>
                    <measurement group_id="O3" value="0.91" spread="0.67"/>
                    <measurement group_id="O4" value="0.67" spread="0.57"/>
                    <measurement group_id="O5" value="0.19" spread="0.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in AUC of Pain Relief Scores (TOTPAR)</title>
        <description>Total pain relief (TOTPAR) was measured using pain assessment diary where subject tick the appropriate box in response to the question 'How much relief have you had from your starting pain?'
Pain Relief (PR) was rated on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete.</description>
        <time_frame>0-4, 0-6, 0-8 and 0-12 hours</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen 200mg + Paracetamol 500mg (Lower Dose)</title>
            <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet by mouth</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose)</title>
            <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg by mouth</description>
          </group>
          <group group_id="O3">
            <title>Nurofen Plus®</title>
            <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®) by mouth</description>
          </group>
          <group group_id="O4">
            <title>Panadeine® Extra</title>
            <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra) by mouth</description>
          </group>
          <group group_id="O5">
            <title>Placebo</title>
            <description>Two placebo tablets by mouth</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in AUC of Pain Relief Scores (TOTPAR)</title>
          <description>Total pain relief (TOTPAR) was measured using pain assessment diary where subject tick the appropriate box in response to the question 'How much relief have you had from your starting pain?'
Pain Relief (PR) was rated on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete.</description>
          <population>ITT population</population>
          <units>units on a scale*hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="173"/>
                <count group_id="O2" value="168"/>
                <count group_id="O3" value="169"/>
                <count group_id="O4" value="113"/>
                <count group_id="O5" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0-4h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.33" spread="0.96"/>
                    <measurement group_id="O2" value="2.48" spread="0.90"/>
                    <measurement group_id="O3" value="2.20" spread="1.04"/>
                    <measurement group_id="O4" value="2.05" spread="1.00"/>
                    <measurement group_id="O5" value="0.42" spread="0.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0-6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.34" spread="1.02"/>
                    <measurement group_id="O2" value="2.56" spread="0.98"/>
                    <measurement group_id="O3" value="2.22" spread="1.12"/>
                    <measurement group_id="O4" value="1.85" spread="1.03"/>
                    <measurement group_id="O5" value="0.41" spread="0.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0-8h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.18" spread="1.05"/>
                    <measurement group_id="O2" value="2.48" spread="1.03"/>
                    <measurement group_id="O3" value="2.08" spread="1.15"/>
                    <measurement group_id="O4" value="1.61" spread="1.01"/>
                    <measurement group_id="O5" value="0.38" spread="0.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0-12h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.73" spread="1.01"/>
                    <measurement group_id="O2" value="2.12" spread="1.06"/>
                    <measurement group_id="O3" value="1.70" spread="1.11"/>
                    <measurement group_id="O4" value="1.27" spread="0.98"/>
                    <measurement group_id="O5" value="0.34" spread="0.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in AUC of Individual Reading Pain Intensity and Relief Scores (SPRID)</title>
        <description>SPRID 0-12h: Sum of pain intensity difference (PID) and the pain relief (PR) score over the twelve-hour follow-up period. Score range: 0mm = No pain and 100mm = Worst pain. This was calculated as the area under the curve (AUC) using the method of linear trapezoids assuming that the baseline assessment took place at time zero.
Pain intensity (PI) was measured by pain assessment questionnaire, where subject tick the appropriate box in a 4-point ordinal scale ranging from 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain, in response to the question 'What is your pain level at this time?'
Total Pain Relief (TOTPAR) was measured using pain assessment diary, where subject tick the appropriate box on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete, in response to the question 'How much relief have you had from your starting pain?'</description>
        <time_frame>15, 30, 45, 60, 90 minutes and 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 hours</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen 200mg + Paracetamol 500mg (Lower Dose)</title>
            <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet by mouth</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose)</title>
            <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg by mouth</description>
          </group>
          <group group_id="O3">
            <title>Nurofen Plus®</title>
            <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®) by mouth</description>
          </group>
          <group group_id="O4">
            <title>Panadeine® Extra</title>
            <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra) by mouth</description>
          </group>
          <group group_id="O5">
            <title>Placebo</title>
            <description>Two placebo tablets by mouth</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in AUC of Individual Reading Pain Intensity and Relief Scores (SPRID)</title>
          <description>SPRID 0-12h: Sum of pain intensity difference (PID) and the pain relief (PR) score over the twelve-hour follow-up period. Score range: 0mm = No pain and 100mm = Worst pain. This was calculated as the area under the curve (AUC) using the method of linear trapezoids assuming that the baseline assessment took place at time zero.
Pain intensity (PI) was measured by pain assessment questionnaire, where subject tick the appropriate box in a 4-point ordinal scale ranging from 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain, in response to the question 'What is your pain level at this time?'
Total Pain Relief (TOTPAR) was measured using pain assessment diary, where subject tick the appropriate box on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete, in response to the question 'How much relief have you had from your starting pain?'</description>
          <population>ITT population</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="173"/>
                <count group_id="O2" value="168"/>
                <count group_id="O3" value="169"/>
                <count group_id="O4" value="113"/>
                <count group_id="O5" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>15 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.12" spread="1.21"/>
                    <measurement group_id="O2" value="1.29" spread="1.38"/>
                    <measurement group_id="O3" value="0.78" spread="1.22"/>
                    <measurement group_id="O4" value="1.01" spread="1.40"/>
                    <measurement group_id="O5" value="0.29" spread="0.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.49" spread="1.63"/>
                    <measurement group_id="O2" value="2.79" spread="1.62"/>
                    <measurement group_id="O3" value="2.08" spread="1.71"/>
                    <measurement group_id="O4" value="2.62" spread="1.83"/>
                    <measurement group_id="O5" value="0.58" spread="1.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.20" spread="1.72"/>
                    <measurement group_id="O2" value="3.52" spread="1.64"/>
                    <measurement group_id="O3" value="2.92" spread="1.84"/>
                    <measurement group_id="O4" value="3.39" spread="1.80"/>
                    <measurement group_id="O5" value="0.65" spread="1.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.71" spread="1.83"/>
                    <measurement group_id="O2" value="4.04" spread="1.66"/>
                    <measurement group_id="O3" value="3.49" spread="1.98"/>
                    <measurement group_id="O4" value="3.81" spread="1.83"/>
                    <measurement group_id="O5" value="0.71" spread="1.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>90 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.12" spread="1.82"/>
                    <measurement group_id="O2" value="4.44" spread="1.69"/>
                    <measurement group_id="O3" value="3.92" spread="2.06"/>
                    <measurement group_id="O4" value="3.96" spread="1.77"/>
                    <measurement group_id="O5" value="0.60" spread="1.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.28" spread="1.95"/>
                    <measurement group_id="O2" value="4.51" spread="1.80"/>
                    <measurement group_id="O3" value="4.17" spread="2.14"/>
                    <measurement group_id="O4" value="3.91" spread="1.90"/>
                    <measurement group_id="O5" value="0.67" spread="1.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.18" spread="2.06"/>
                    <measurement group_id="O2" value="4.53" spread="1.95"/>
                    <measurement group_id="O3" value="4.02" spread="2.14"/>
                    <measurement group_id="O4" value="3.31" spread="2.13"/>
                    <measurement group_id="O5" value="1.66" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.08" spread="2.09"/>
                    <measurement group_id="O2" value="4.46" spread="2.09"/>
                    <measurement group_id="O3" value="3.78" spread="2.31"/>
                    <measurement group_id="O4" value="2.79" spread="2.21"/>
                    <measurement group_id="O5" value="0.64" spread="1.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.77" spread="2.21"/>
                    <measurement group_id="O2" value="4.36" spread="2.12"/>
                    <measurement group_id="O3" value="3.52" spread="2.40"/>
                    <measurement group_id="O4" value="2.23" spread="2.20"/>
                    <measurement group_id="O5" value="0.60" spread="1.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.06" spread="2.34"/>
                    <measurement group_id="O2" value="3.98" spread="2.24"/>
                    <measurement group_id="O3" value="2.98" spread="2.47"/>
                    <measurement group_id="O4" value="1.70" spread="2.16"/>
                    <measurement group_id="O5" value="0.53" spread="1.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.56" spread="2.37"/>
                    <measurement group_id="O2" value="3.51" spread="2.40"/>
                    <measurement group_id="O3" value="2.54" spread="2.50"/>
                    <measurement group_id="O4" value="1.31" spread="2.00"/>
                    <measurement group_id="O5" value="0.45" spread="1.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.09" spread="2.31"/>
                    <measurement group_id="O2" value="2.79" spread="2.49"/>
                    <measurement group_id="O3" value="2.08" spread="2.38"/>
                    <measurement group_id="O4" value="1.02" spread="1.92"/>
                    <measurement group_id="O5" value="0.40" spread="1.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.57" spread="2.20"/>
                    <measurement group_id="O2" value="2.53" spread="2.47"/>
                    <measurement group_id="O3" value="1.68" spread="2.20"/>
                    <measurement group_id="O4" value="0.91" spread="1.87"/>
                    <measurement group_id="O5" value="0.47" spread="1.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.21" spread="2.02"/>
                    <measurement group_id="O2" value="2.04" spread="2.34"/>
                    <measurement group_id="O3" value="1.30" spread="2.06"/>
                    <measurement group_id="O4" value="0.81" spread="1.84"/>
                    <measurement group_id="O5" value="0.49" spread="1.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.90" spread="1.83"/>
                    <measurement group_id="O2" value="1.63" spread="2.24"/>
                    <measurement group_id="O3" value="1.12" spread="2.02"/>
                    <measurement group_id="O4" value="0.76" spread="1.77"/>
                    <measurement group_id="O5" value="0.49" spread="1.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.69" spread="1.64"/>
                    <measurement group_id="O2" value="1.34" spread="2.14"/>
                    <measurement group_id="O3" value="0.96" spread="1.85"/>
                    <measurement group_id="O4" value="0.74" spread="1.76"/>
                    <measurement group_id="O5" value="0.49" spread="1.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Individual Pain Intensity Differences (Ordinal)</title>
        <description>Pain intensity (PI) was measured by pain assessment questionnaire where subject tick the appropriate box in response to the question 'What is your pain level at this time?'
PI measured using a 4-point ordinal scale: 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain.</description>
        <time_frame>15, 30, 45, 60, 90 minutes and 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 hours</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen 200mg + Paracetamol 500mg (Lower Dose)</title>
            <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet by mouth</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose)</title>
            <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg by mouth</description>
          </group>
          <group group_id="O3">
            <title>Nurofen Plus®</title>
            <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®) by mouth</description>
          </group>
          <group group_id="O4">
            <title>Panadeine® Extra</title>
            <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra) by mouth</description>
          </group>
          <group group_id="O5">
            <title>Placebo</title>
            <description>Two placebo tablets by mouth</description>
          </group>
        </group_list>
        <measure>
          <title>Individual Pain Intensity Differences (Ordinal)</title>
          <description>Pain intensity (PI) was measured by pain assessment questionnaire where subject tick the appropriate box in response to the question 'What is your pain level at this time?'
PI measured using a 4-point ordinal scale: 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain.</description>
          <population>ITT population</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="173"/>
                <count group_id="O2" value="168"/>
                <count group_id="O3" value="169"/>
                <count group_id="O4" value="113"/>
                <count group_id="O5" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>15 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" spread="0.57"/>
                    <measurement group_id="O2" value="0.46" spread="0.64"/>
                    <measurement group_id="O3" value="0.23" spread="0.58"/>
                    <measurement group_id="O4" value="0.31" spread="0.64"/>
                    <measurement group_id="O5" value="0.09" spread="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.94" spread="0.76"/>
                    <measurement group_id="O2" value="1.03" spread="0.74"/>
                    <measurement group_id="O3" value="0.73" spread="0.80"/>
                    <measurement group_id="O4" value="0.95" spread="0.83"/>
                    <measurement group_id="O5" value="0.15" spread="0.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.14" spread="0.76"/>
                    <measurement group_id="O2" value="1.27" spread="0.76"/>
                    <measurement group_id="O3" value="1.04" spread="0.80"/>
                    <measurement group_id="O4" value="1.19" spread="0.83"/>
                    <measurement group_id="O5" value="0.16" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.31" spread="0.85"/>
                    <measurement group_id="O2" value="1.48" spread="0.79"/>
                    <measurement group_id="O3" value="1.24" spread="0.87"/>
                    <measurement group_id="O4" value="1.35" spread="0.85"/>
                    <measurement group_id="O5" value="0.22" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>90 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.49" spread="0.83"/>
                    <measurement group_id="O2" value="1.61" spread="0.84"/>
                    <measurement group_id="O3" value="1.40" spread="0.92"/>
                    <measurement group_id="O4" value="1.42" spread="0.83"/>
                    <measurement group_id="O5" value="0.11" spread="0.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.54" spread="0.89"/>
                    <measurement group_id="O2" value="1.69" spread="0.87"/>
                    <measurement group_id="O3" value="1.52" spread="0.94"/>
                    <measurement group_id="O4" value="1.41" spread="0.84"/>
                    <measurement group_id="O5" value="0.24" spread="0.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.54" spread="0.91"/>
                    <measurement group_id="O2" value="1.70" spread="0.89"/>
                    <measurement group_id="O3" value="1.46" spread="0.93"/>
                    <measurement group_id="O4" value="1.19" spread="0.87"/>
                    <measurement group_id="O5" value="0.22" spread="0.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.49" spread="0.91"/>
                    <measurement group_id="O2" value="1.68" spread="0.94"/>
                    <measurement group_id="O3" value="1.36" spread="0.95"/>
                    <measurement group_id="O4" value="0.96" spread="0.90"/>
                    <measurement group_id="O5" value="0.24" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.35" spread="0.93"/>
                    <measurement group_id="O2" value="1.60" spread="0.93"/>
                    <measurement group_id="O3" value="1.24" spread="0.96"/>
                    <measurement group_id="O4" value="0.79" spread="0.88"/>
                    <measurement group_id="O5" value="0.22" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.07" spread="0.93"/>
                    <measurement group_id="O2" value="1.44" spread="0.93"/>
                    <measurement group_id="O3" value="1.04" spread="0.95"/>
                    <measurement group_id="O4" value="0.58" spread="0.82"/>
                    <measurement group_id="O5" value="0.20" spread="0.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.89" spread="0.93"/>
                    <measurement group_id="O2" value="1.22" spread="0.98"/>
                    <measurement group_id="O3" value="0.88" spread="0.96"/>
                    <measurement group_id="O4" value="0.44" spread="0.74"/>
                    <measurement group_id="O5" value="0.18" spread="0.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.71" spread="0.89"/>
                    <measurement group_id="O2" value="0.96" spread="0.96"/>
                    <measurement group_id="O3" value="0.72" spread="0.89"/>
                    <measurement group_id="O4" value="0.33" spread="0.71"/>
                    <measurement group_id="O5" value="0.16" spread="0.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.53" spread="0.80"/>
                    <measurement group_id="O2" value="0.86" spread="0.94"/>
                    <measurement group_id="O3" value="0.55" spread="0.80"/>
                    <measurement group_id="O4" value="0.29" spread="0.68"/>
                    <measurement group_id="O5" value="0.20" spread="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" spread="0.74"/>
                    <measurement group_id="O2" value="0.67" spread="0.87"/>
                    <measurement group_id="O3" value="0.43" spread="0.75"/>
                    <measurement group_id="O4" value="0.27" spread="0.67"/>
                    <measurement group_id="O5" value="0.20" spread="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" spread="0.64"/>
                    <measurement group_id="O2" value="0.52" spread="0.80"/>
                    <measurement group_id="O3" value="0.36" spread="0.73"/>
                    <measurement group_id="O4" value="0.24" spread="0.63"/>
                    <measurement group_id="O5" value="0.20" spread="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" spread="0.57"/>
                    <measurement group_id="O2" value="0.42" spread="0.78"/>
                    <measurement group_id="O3" value="0.30" spread="0.63"/>
                    <measurement group_id="O4" value="0.25" spread="0.63"/>
                    <measurement group_id="O5" value="0.20" spread="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Individual Pain Intensity Differences Visual Analogue Scale (VAS)</title>
        <description>Pain Intensity (PI) VAS was measured using a horizontal 100-mm VAS ranging 0 mm = 'No Pain' as the left anchor and 100 mm = 'Worst Pain' as the right anchor, labelled by the subject marking the VAS line in the pain assessment questionnaire in response to the instruction 'Please indicate with a line on the scale below your pain at this time.'</description>
        <time_frame>15, 30, 45, 60, 90 minutes and 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 hours</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen 200mg + Paracetamol 500mg (Lower Dose)</title>
            <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet by mouth</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose)</title>
            <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg by mouth</description>
          </group>
          <group group_id="O3">
            <title>Nurofen Plus®</title>
            <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®) by mouth</description>
          </group>
          <group group_id="O4">
            <title>Panadeine® Extra</title>
            <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra) by mouth</description>
          </group>
          <group group_id="O5">
            <title>Placebo</title>
            <description>Two placebo tablets by mouth</description>
          </group>
        </group_list>
        <measure>
          <title>Individual Pain Intensity Differences Visual Analogue Scale (VAS)</title>
          <description>Pain Intensity (PI) VAS was measured using a horizontal 100-mm VAS ranging 0 mm = 'No Pain' as the left anchor and 100 mm = 'Worst Pain' as the right anchor, labelled by the subject marking the VAS line in the pain assessment questionnaire in response to the instruction 'Please indicate with a line on the scale below your pain at this time.'</description>
          <population>ITT population</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="173"/>
                <count group_id="O2" value="168"/>
                <count group_id="O3" value="169"/>
                <count group_id="O4" value="113"/>
                <count group_id="O5" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>15 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.0" spread="13.7"/>
                    <measurement group_id="O2" value="10.5" spread="16.3"/>
                    <measurement group_id="O3" value="4.5" spread="14.1"/>
                    <measurement group_id="O4" value="8.7" spread="16.6"/>
                    <measurement group_id="O5" value="0.4" spread="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.8" spread="21.4"/>
                    <measurement group_id="O2" value="26.2" spread="21.5"/>
                    <measurement group_id="O3" value="17.7" spread="22.5"/>
                    <measurement group_id="O4" value="23.9" spread="23.9"/>
                    <measurement group_id="O5" value="2.2" spread="16.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.5" spread="23.8"/>
                    <measurement group_id="O2" value="37.5" spread="24.0"/>
                    <measurement group_id="O3" value="28.3" spread="25.7"/>
                    <measurement group_id="O4" value="34.3" spread="25.7"/>
                    <measurement group_id="O5" value="0.9" spread="18.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.3" spread="25.5"/>
                    <measurement group_id="O2" value="46.3" spread="24.4"/>
                    <measurement group_id="O3" value="36.6" spread="28.7"/>
                    <measurement group_id="O4" value="41.5" spread="27.1"/>
                    <measurement group_id="O5" value="1.8" spread="19.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>90 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.3" spread="25.8"/>
                    <measurement group_id="O2" value="52.5" spread="24.8"/>
                    <measurement group_id="O3" value="43.7" spread="28.2"/>
                    <measurement group_id="O4" value="44.6" spread="25.9"/>
                    <measurement group_id="O5" value="0.9" spread="22.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.6" spread="26.6"/>
                    <measurement group_id="O2" value="54.9" spread="25.7"/>
                    <measurement group_id="O3" value="47.3" spread="29.3"/>
                    <measurement group_id="O4" value="45.2" spread="27.9"/>
                    <measurement group_id="O5" value="5.0" spread="18.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.0" spread="27.1"/>
                    <measurement group_id="O2" value="55.9" spread="25.5"/>
                    <measurement group_id="O3" value="48.0" spread="29.3"/>
                    <measurement group_id="O4" value="38.9" spread="29.9"/>
                    <measurement group_id="O5" value="6.1" spread="21.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.2" spread="27.8"/>
                    <measurement group_id="O2" value="55.5" spread="26.4"/>
                    <measurement group_id="O3" value="45.6" spread="29.9"/>
                    <measurement group_id="O4" value="32.9" spread="29.4"/>
                    <measurement group_id="O5" value="7.2" spread="20.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.4" spread="28.7"/>
                    <measurement group_id="O2" value="52.8" spread="26.7"/>
                    <measurement group_id="O3" value="42.5" spread="30.4"/>
                    <measurement group_id="O4" value="25.9" spread="29.2"/>
                    <measurement group_id="O5" value="7.2" spread="19.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.6" spread="30.2"/>
                    <measurement group_id="O2" value="47.9" spread="27.8"/>
                    <measurement group_id="O3" value="35.6" spread="30.6"/>
                    <measurement group_id="O4" value="18.4" spread="27.2"/>
                    <measurement group_id="O5" value="6.5" spread="19.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.9" spread="30.6"/>
                    <measurement group_id="O2" value="41.0" spread="29.8"/>
                    <measurement group_id="O3" value="29.7" spread="30.8"/>
                    <measurement group_id="O4" value="15.4" spread="25.2"/>
                    <measurement group_id="O5" value="5.8" spread="18.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.0" spread="28.9"/>
                    <measurement group_id="O2" value="33.8" spread="30.8"/>
                    <measurement group_id="O3" value="24.4" spread="29.8"/>
                    <measurement group_id="O4" value="11.7" spread="24.4"/>
                    <measurement group_id="O5" value="5.1" spread="17.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.7" spread="26.4"/>
                    <measurement group_id="O2" value="29.6" spread="30.3"/>
                    <measurement group_id="O3" value="18.4" spread="27.2"/>
                    <measurement group_id="O4" value="10.8" spread="22.9"/>
                    <measurement group_id="O5" value="5.6" spread="19.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.1" spread="25.2"/>
                    <measurement group_id="O2" value="23.7" spread="29.1"/>
                    <measurement group_id="O3" value="14.9" spread="25.3"/>
                    <measurement group_id="O4" value="9.7" spread="22.9"/>
                    <measurement group_id="O5" value="6.2" spread="20.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.4" spread="21.2"/>
                    <measurement group_id="O2" value="18.7" spread="27.2"/>
                    <measurement group_id="O3" value="12.8" spread="24.7"/>
                    <measurement group_id="O4" value="9.8" spread="23.2"/>
                    <measurement group_id="O5" value="6.2" spread="20.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" spread="20.4"/>
                    <measurement group_id="O2" value="15.1" spread="25.5"/>
                    <measurement group_id="O3" value="11.0" spread="22.9"/>
                    <measurement group_id="O4" value="9.3" spread="22.1"/>
                    <measurement group_id="O5" value="6.4" spread="20.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Peak Pain Intensity Difference (Peak PID - Ordinal)</title>
        <description>Pain intensity (PI) was measured by pain assessment questionnaire where subject tick the appropriate box in response to the question 'What is your pain level at this time?'
PI measured using a 4-point ordinal scale: 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain.</description>
        <time_frame>0 (baseline), 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 hours post-dose</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen 200mg + Paracetamol 500mg (Lower Dose)</title>
            <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet by mouth</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose)</title>
            <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg by mouth</description>
          </group>
          <group group_id="O3">
            <title>Nurofen Plus®</title>
            <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®) by mouth</description>
          </group>
          <group group_id="O4">
            <title>Panadeine® Extra</title>
            <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra) by mouth</description>
          </group>
          <group group_id="O5">
            <title>Placebo</title>
            <description>Two placebo tablets by mouth</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Peak Pain Intensity Difference (Peak PID - Ordinal)</title>
          <description>Pain intensity (PI) was measured by pain assessment questionnaire where subject tick the appropriate box in response to the question 'What is your pain level at this time?'
PI measured using a 4-point ordinal scale: 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain.</description>
          <population>ITT population</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="173"/>
                <count group_id="O2" value="168"/>
                <count group_id="O3" value="169"/>
                <count group_id="O4" value="113"/>
                <count group_id="O5" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.78" spread="0.83"/>
                    <measurement group_id="O2" value="1.93" spread="0.81"/>
                    <measurement group_id="O3" value="1.74" spread="0.87"/>
                    <measurement group_id="O4" value="1.63" spread="0.77"/>
                    <measurement group_id="O5" value="0.60" spread="0.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Peak Pain Relief (PR)</title>
        <description>Total pain relief (TOTPAR) was measured using pain assessment diary where subject tick the appropriate box in response to the question 'How much relief have you had from your starting pain?'
Pain Relief (PR) was rated on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete.</description>
        <time_frame>0 (baseline), 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 hours post-dose</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen 200mg + Paracetamol 500mg (Lower Dose)</title>
            <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet by mouth</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose)</title>
            <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg by mouth</description>
          </group>
          <group group_id="O3">
            <title>Nurofen Plus®</title>
            <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®) by mouth</description>
          </group>
          <group group_id="O4">
            <title>Panadeine® Extra</title>
            <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra) by mouth</description>
          </group>
          <group group_id="O5">
            <title>Placebo</title>
            <description>Two placebo tablets by mouth</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Peak Pain Relief (PR)</title>
          <description>Total pain relief (TOTPAR) was measured using pain assessment diary where subject tick the appropriate box in response to the question 'How much relief have you had from your starting pain?'
Pain Relief (PR) was rated on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete.</description>
          <population>ITT population</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="173"/>
                <count group_id="O2" value="168"/>
                <count group_id="O3" value="169"/>
                <count group_id="O4" value="113"/>
                <count group_id="O5" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.06" spread="1.00"/>
                    <measurement group_id="O2" value="3.25" spread="0.89"/>
                    <measurement group_id="O3" value="2.98" spread="1.11"/>
                    <measurement group_id="O4" value="2.88" spread="1.00"/>
                    <measurement group_id="O5" value="0.96" spread="1.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjects' Overall Assessment of the Study Medication Assessed at 12 Hours or Just Before Administration of Rescue Medication</title>
        <description>Subject's Overall Assessment measured by subject ticking the appropriate box in response to the question 'How effective do you think the study medication is as a treatment for pain?'
Subject's Overall Assessment rated on a five-point ordinal scale: 1 = Poor, 2 = Fair, 3 = Good, 4 = Very good, and 5 = Excellent.</description>
        <time_frame>At 12 hours</time_frame>
        <population>Three subjects from ITT population were excluded from this analysis due to early/late diary assessments.</population>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen 200mg + Paracetamol 500mg (Lower Dose)</title>
            <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet by mouth</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose)</title>
            <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg by mouth</description>
          </group>
          <group group_id="O3">
            <title>Nurofen Plus®</title>
            <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®) by mouth</description>
          </group>
          <group group_id="O4">
            <title>Panadeine® Extra</title>
            <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra) by mouth</description>
          </group>
          <group group_id="O5">
            <title>Placebo</title>
            <description>Two placebo tablets by mouth</description>
          </group>
        </group_list>
        <measure>
          <title>Subjects' Overall Assessment of the Study Medication Assessed at 12 Hours or Just Before Administration of Rescue Medication</title>
          <description>Subject's Overall Assessment measured by subject ticking the appropriate box in response to the question 'How effective do you think the study medication is as a treatment for pain?'
Subject's Overall Assessment rated on a five-point ordinal scale: 1 = Poor, 2 = Fair, 3 = Good, 4 = Very good, and 5 = Excellent.</description>
          <population>Three subjects from ITT population were excluded from this analysis due to early/late diary assessments.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="169"/>
                <count group_id="O2" value="165"/>
                <count group_id="O3" value="167"/>
                <count group_id="O4" value="113"/>
                <count group_id="O5" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 Poor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 Fair</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="32"/>
                    <measurement group_id="O3" value="40"/>
                    <measurement group_id="O4" value="41"/>
                    <measurement group_id="O5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 Very good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                    <measurement group_id="O2" value="69"/>
                    <measurement group_id="O3" value="64"/>
                    <measurement group_id="O4" value="34"/>
                    <measurement group_id="O5" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 Excellent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="39"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to Day 10 (follow-up)</time_frame>
      <desc>A treatment emergent adverse event is any event commencing within 12 hours of study medication dose.</desc>
      <group_list>
        <group group_id="E1">
          <title>Ibuprofen 200mg + Paracetamol 500mg (Lower Dose)</title>
          <description>One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet by mouth</description>
        </group>
        <group group_id="E2">
          <title>Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose)</title>
          <description>Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg by mouth</description>
        </group>
        <group group_id="E3">
          <title>Nurofen Plus®</title>
          <description>Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®) by mouth</description>
        </group>
        <group group_id="E4">
          <title>Panadeine® Extra</title>
          <description>Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra) by mouth</description>
        </group>
        <group group_id="E5">
          <title>Placebo</title>
          <description>Two placebo tablets by mouth</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="113"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="55"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="169"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="113"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 12.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="88" subjects_at_risk="173"/>
                <counts group_id="E2" subjects_affected="87" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="97" subjects_at_risk="169"/>
                <counts group_id="E4" subjects_affected="72" subjects_at_risk="113"/>
                <counts group_id="E5" subjects_affected="35" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="49" subjects_affected="43" subjects_at_risk="173"/>
                <counts group_id="E2" events="36" subjects_affected="33" subjects_at_risk="168"/>
                <counts group_id="E3" events="57" subjects_affected="50" subjects_at_risk="169"/>
                <counts group_id="E4" events="49" subjects_affected="37" subjects_at_risk="113"/>
                <counts group_id="E5" events="19" subjects_affected="18" subjects_at_risk="55"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="32" subjects_affected="29" subjects_at_risk="173"/>
                <counts group_id="E2" events="34" subjects_affected="30" subjects_at_risk="168"/>
                <counts group_id="E3" events="41" subjects_affected="35" subjects_at_risk="169"/>
                <counts group_id="E4" events="29" subjects_affected="25" subjects_at_risk="113"/>
                <counts group_id="E5" events="13" subjects_affected="13" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Alveolar osteitis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="173"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="168"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="169"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="113"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Body temperature increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="173"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="168"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="169"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="113"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title vocab="undefined">Dizziness</sub_title>
                <counts group_id="E1" events="13" subjects_affected="12" subjects_at_risk="173"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="168"/>
                <counts group_id="E3" events="24" subjects_affected="23" subjects_at_risk="169"/>
                <counts group_id="E4" events="14" subjects_affected="14" subjects_at_risk="113"/>
                <counts group_id="E5" events="4" subjects_affected="3" subjects_at_risk="55"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="23" subjects_affected="19" subjects_at_risk="173"/>
                <counts group_id="E2" events="21" subjects_affected="19" subjects_at_risk="168"/>
                <counts group_id="E3" events="35" subjects_affected="32" subjects_at_risk="169"/>
                <counts group_id="E4" events="30" subjects_affected="21" subjects_at_risk="113"/>
                <counts group_id="E5" events="11" subjects_affected="10" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Investigator must submit any proposed manuscript to RB for approval prior to submission for publication. No timelines are stated. However, note that the results of this study have already been published.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Research Director, Clinical Research</name_or_title>
      <organization>Reckitt Benckiser Healthcare International</organization>
      <email>clinicalrequests@rb.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

